Eli Lilly & Co. (LLY)
1257.03
+5.42
(+0.43%)
USD |
NYSE |
Oct 16, 16:00
1256.79
-0.24
(-0.02%)
After-Hours: 20:00
Eli Lilly Gross Profit Margin (Quarterly) : 85.78% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.78% |
| March 31, 2026 | 81.93% |
| December 31, 2025 | 82.52% |
| September 30, 2025 | 82.91% |
| June 30, 2025 | 84.27% |
| March 31, 2025 | 82.53% |
| December 31, 2024 | 82.24% |
| September 30, 2024 | 81.02% |
| June 30, 2024 | 80.80% |
| March 31, 2024 | 80.91% |
| December 31, 2023 | 80.88% |
| September 30, 2023 | 80.42% |
| June 30, 2023 | 78.26% |
| March 31, 2023 | 76.63% |
| December 31, 2022 | 78.80% |
| September 30, 2022 | 77.25% |
| June 30, 2022 | 77.95% |
| March 31, 2022 | 73.47% |
| December 31, 2021 | 74.37% |
| September 30, 2021 | 78.87% |
| June 30, 2021 | 71.02% |
| March 31, 2021 | 72.40% |
| December 31, 2020 | 76.88% |
| September 30, 2020 | 76.89% |
| June 30, 2020 | 77.78% |
| Date | Value |
|---|---|
| March 31, 2020 | 79.26% |
| December 31, 2019 | 79.02% |
| September 30, 2019 | 78.55% |
| June 30, 2019 | 80.04% |
| March 31, 2019 | 77.64% |
| December 31, 2018 | 79.96% |
| September 30, 2018 | 78.28% |
| June 30, 2018 | 77.90% |
| March 31, 2018 | 76.54% |
| December 31, 2017 | 73.63% |
| September 30, 2017 | 72.32% |
| June 30, 2017 | 73.36% |
| March 31, 2017 | 74.61% |
| December 31, 2016 | 74.55% |
| September 30, 2016 | 73.02% |
| June 30, 2016 | 72.89% |
| March 31, 2016 | 72.81% |
| December 31, 2015 | 74.16% |
| September 30, 2015 | 75.06% |
| June 30, 2015 | 75.53% |
| March 31, 2015 | 74.32% |
| December 31, 2014 | 75.53% |
| September 30, 2014 | 74.01% |
| June 30, 2014 | 75.90% |
| March 31, 2014 | 73.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 73.00% |
| Merck & Co., Inc. | 71.51% |
| Pfizer Inc. | 62.94% |
| Bristol Myers Squibb Co. | 67.95% |
| Structure Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 99.80% |
| Return on Assets | 22.74% |
| Return on Invested Capital | 37.27% |
| Profit Margin (Quarterly) | 30.88% |
| Operating Margin (Quarterly) | 54.22% |
| Return on Net Operating Assets | 30.49% |